The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy

by Chaurasia, S.S, Lim, R.R, Parikh, B.H, Wey, Y.S, Tun, B.B, Wong, T.Y, Luu, C.D, Agrawal, R, Ghosh, A, Mortellaro, A, Rackoczy, E, Mohan, R.R, Barathi, V.A
Published 2020

Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases

by Regula, J.T, Lundh von Leithner, P, Foxton, R, Barathi, V.A, Cheung, C.M.G, Bo Tun, S.B, Wey, Y.S, Iwata, D, Dostalek, M, Moelleken, J, Stubenrauch, K.G, Nogoceke, E, Widmer, G, Strassburger, P, Koss, M.J, Klein, C, Shima, D.T, Hartmann, G
Published 2020

Erratum to: Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases (EMBO Molecular Medicine, (2016), 8, 11, (1265-1288), 10.15252/emmm....

by Regula, J.T., Lundh von Leithner, P., Foxton, R., Barathi, V.A., Gemmy Cheung, C.M., Bo Tun, S.B., Wey, Y.S., Iwata, D., Dostalek, M., Moelleken, J., Stubenrauch, K.G., Nogoceke, E., Widmer, G., Strassburger, P., Koss, M.J., Klein, C., Shima, D.T., Hartmann, G.
Published 2020